BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv Y, Fan D. Hepatopulmonary Syndrome. Dig Dis Sci. 2015;60:1914-1923. [PMID: 25732713 DOI: 10.1007/s10620-015-3593-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang S, Chen C, Peng J, Li X, Zhang D, Yan J, Zhang Y, Lu C, Xun J, Li W, Ling Y, Huang Y, Chen L. Investigation of underlying comorbidities as risk factors for symptomatic human hepatitis E virus infection. Aliment Pharmacol Ther 2017;45:701-13. [DOI: 10.1111/apt.13938] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
2 Warner S, Mckiernan PJ, Hartley J, Ong E, van Mourik ID, Gupte G, Abdel-hady M, Muiesan P, Perera T, Mirza D, Sharif K, Kelly DA, Beath SV. Hepatopulmonary Syndrome in Children: A 20-Year Review of Presenting Symptoms, Clinical Progression, and Transplant Outcome. Liver Transpl 2018;24:1271-9. [DOI: 10.1002/lt.25296] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
3 Beshlawy AE, Murugesan V, Mistry PK, Eid K. Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy. Mol Genet Metab Rep 2019;20:100490. [PMID: 31309038 DOI: 10.1016/j.ymgmr.2019.100490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Melchio R, Margaria F, Bracco C, Pomero F, Fenoglio LM. Respiratory failure in portal hypertension: at the heart of the matter. Intern Emerg Med 2016;11:721-2. [DOI: 10.1007/s11739-016-1413-y] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Jung D, Seo GH, Kim YM, Choi JH, Yoo HW. Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: a case report. Ann Pediatr Endocrinol Metab 2018;23:51-5. [PMID: 29609450 DOI: 10.6065/apem.2018.23.1.51] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bertino G, Privitera G, Purrello F, Demma S, Crisafulli E, Spadaro L, Koukias N, Tsochatzis EA. Emerging hepatic syndromes: pathophysiology, diagnosis and treatment. Intern Emerg Med 2016;11:905-16. [DOI: 10.1007/s11739-016-1478-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
7 Zhang L, Zhang H, Wang L, Fan Y, Zhang C, Li X, Han D, Ji C. Protective Effects of Emodin on Lung Injuries in Rat Models of Liver Fibrosis. Open Life Sci 2019;14:611-8. [PMID: 33817199 DOI: 10.1515/biol-2019-0069] [Reference Citation Analysis]
8 Zhang XY, Yuan K, Fang YL, Wang CL. Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in a child: A case report. World J Clin Cases 2022; 10(18): 6211-6217 [DOI: 10.12998/wjcc.v10.i18.6211] [Reference Citation Analysis]
9 Nasser I, Miranda H, Perez RM, Cabiddu R, Malosa L, Dias I, Brown A, Reis MS. Limited cardiopulmonary capacity in patients with liver cirrhosis when compared to healthy subjects. Rev Assoc Med Bras (1992) 2021;67:94-100. [PMID: 34161483 DOI: 10.1590/1806-9282.67.01.20200449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Surani SR, Mendez Y, Anjum H, Varon J. Pulmonary complications of hepatic diseases. World J Gastroenterol 2016; 22(26): 6008-6015 [PMID: 27468192 DOI: 10.3748/wjg.v22.i26.6008] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
11 Gao J, Yu H, Bai X, Liu C, Chen L, Belguise K, Wang X, Lu K, Hu Z, Yi B. Loss of cell polarity regulated by PTEN/Cdc42 enrolled in the process of Hepatopulmonary Syndrome. J Cell Mol Med 2019;23:5542-52. [PMID: 31144461 DOI: 10.1111/jcmm.14437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
12 Chen C, Zhang SY, Zhang DD, Li XY, Zhang YL, Li WX, Yan JJ, Wang M, Xun JN, Lu C, Ling Y, Huang YX, Chen L. Clinical features of acute hepatitis E super-infections on chronic hepatitis B. World J Gastroenterol 2016; 22(47): 10388-10397 [PMID: 28058019 DOI: 10.3748/wjg.v22.i47.10388] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
13 Gandhi KD, Taweesedt PT, Sharma M, Surani S. Hepatopulmonary syndrome: An update. World J Hepatol 2021; 13(11): 1699-1706 [PMID: 34904039 DOI: 10.4254/wjh.v13.i11.1699] [Reference Citation Analysis]
14 Rose SCP, Cunha DV, Medeiros SBC, Trevizoli JE, Carneiro MV, Freitas WM, Mendes LSC. Correlation between hepatopulmonary syndrome and oxygen saturation pulse oximetry in cirrhotic patients. Rev Assoc Med Bras (1992) 2020;66:1577-82. [PMID: 33295413 DOI: 10.1590/1806-9282.66.11.1577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Fragaki M, Sifaki-Pistolla D, Samonakis DN, Koulentaki M, Koukouraki S, Stathaki M, Kouroumalis E. Screening for Hepatopulmonary Syndrome in Cirrhotic Patients Using Technetium 99m-macroaggregated Albumin Perfusion Lung Scan (Tc-MAA): Diagnostic Approach and Clinical Correlations. J Clin Gastroenterol 2018;52:828-34. [PMID: 28961571 DOI: 10.1097/MCG.0000000000000926] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
16 Shen CC, Chen B, Gu JT, Ning JL, Zeng J, Yi B, Lu KZ. AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs. Biochim Biophys Acta Mol Basis Dis 2018;1864:676-84. [PMID: 29233725 DOI: 10.1016/j.bbadis.2017.12.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
17 Muriel P, Fernández-martínez E, Montes S. Complications of Cirrhosis. Liver Pathophysiology. Elsevier; 2017. pp. 427-33. [DOI: 10.1016/b978-0-12-804274-8.00033-3] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Grilo-Bensusan I, Pascasio-Acevedo JM. Hepatopulmonary syndrome: What we know and what we would like to know. World J Gastroenterol 2016; 22(25): 5728-5741 [PMID: 27433086 DOI: 10.3748/wjg.v22.i25.5728] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
19 Bera C, Thangaraj K, Pati PK, Ramachandran J, Balasubramanian KA, Ramachandran A, Zachariah U, Sajith KG, Goel A, Eapen CE. Raised plasma levels of H2S and nitrate predict intrapulmonary vascular dilations: A preliminary report in patients with cryptogenic cirrhosis. Indian J Gastroenterol 2018;37:209-14. [PMID: 29984390 DOI: 10.1007/s12664-018-0862-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Corbi LE, Tannuri ACA, de Aro Braz MJ, Paes VR, Sbragia L, Figueira RL, da Costa KM, Coelho MCM, Gonçalves JO, Serafini S, Tannuri U. Does Biliodigestive Anastomosis Have Any Effect on the Reversal of Hepatopulmonary Syndrome in a Biliary Cirrhosis Experimental Model? Dig Dis Sci 2019;64:3192-202. [PMID: 31076984 DOI: 10.1007/s10620-019-05658-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]